Neutraceutical or pharmaceutical compositions, useful for treating or preventing cardiovascular disease and atheromatous conditions, comprise alpha-linolenic acid and fatty acids having 5- and 6-double bonds

摘要

Neutraceutical or pharmaceutical compositions (I) having a high unsaturated fatty acid content contain alpha-linolenic acid (ALA) (in free or combined form) at 70-90 wt. %, together with fatty acids having 5- and 6-double bonds, and are in the form of capsules, granules, powder on a powdered carrier or drinkable emulsions.